ACC 2017 Poll
Results from several clinical trials will be reported at the American College of Cardiology meeting in Washington, DC.
Phase 3 EINSTEIN CHOICE study shows Xarelto 10mg reduced the risk of recurrent VTE by 74%
Eliot Brinton, MD, FAHA, FNLA, president and director of the Utah Lipid Center, discusses the benefits of fasting lipid profiles in predicting cardiovascular risk.
Highlights from the 2017 American College of Cardiology Scientific Session & Expo.